Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	4,512	4,405	2,815	4,161	3,430	3,218
Market Cap Growth	58.12%	56.48%	-32.36%	21.31%	6.59%	-46.51%
Enterprise Value	4,661	4,584	3,010	4,335	3,527	3,101
Last Close Price	14.37	14.24	9.42	14.19	12.21	11.55
Forward PE	41.65	59.68	87.63	-	-	-
PS Ratio	7.11	6.95	5.33	10.42	10.42	10.53
PB Ratio	16.29	16.06	14.51	25.98	27.88	10.47
P/TBV Ratio	72.16	70.44	-	-	-	29.37
P/FCF Ratio	151.17	147.56	-	-	-	-
P/OCF Ratio	136.13	132.89	-	-	-	-
EV/Sales Ratio	7.35	7.23	5.70	10.86	10.71	10.15
EV/EBITDA Ratio	111.11	109.26	70.63	-	-	-
EV/EBIT Ratio	135.14	132.89	88.35	-	-	-
EV/FCF Ratio	156.15	153.56	-	-	-	-
Debt / Equity Ratio	1.61	1.61	2.29	2.78	3.67	1.43
Debt / EBITDA Ratio	8.73	8.73	8.61	-	-	-
Debt / FCF Ratio	14.82	14.82	-	-	-	-
Net Debt / Equity Ratio	0.54	0.54	1.00	0.99	1.29	-0.14
Net Debt / EBITDA Ratio	3.55	3.55	4.55	-2.42	-0.80	0.22
Net Debt / FCF Ratio	4.99	4.99	-5.17	-2.08	-0.93	0.21
Asset Turnover	0.73	0.73	0.68	0.53	0.40	0.34
Inventory Turnover	0.42	0.42	0.59	0.89	1.53	1.49
Quick Ratio	1.72	1.72	2.36	2.23	2.59	3.67
Current Ratio	2.84	2.84	3.39	2.88	3.05	4.09
Return on Equity (ROE)	-11.58%	-11.58%	-31.68%	-107.04%	-109.93%	-84.37%
Return on Assets (ROA)	2.48%	2.48%	2.72%	-6.12%	-15.68%	-13.95%
Return on Invested Capital (ROIC)	-1176.15%	-1207.57%	9.64%	-24.47%	-74.80%	-78.42%
Return on Capital Employed (ROCE)	4.80%	4.80%	5.40%	-12.00%	-34.90%	-26.30%
Earnings Yield	-0.60%	-0.61%	-1.99%	-3.64%	-6.90%	-7.78%
FCF Yield	0.66%	0.68%	-1.33%	-1.84%	-4.97%	-6.41%
Buyback Yield / Dilution	-1.31%	-1.31%	-3.12%	-2.11%	-6.50%	-4.85%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q